Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extimia vs Filgrastim for Neutropenia Prophylaxis in Breast Cancer
NCT02104830Phase 3Completed
- Sponsor
- BIOCAD
- Start
- Sep 2013
- Primary completion
- Jun 2014
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of empegfilgrastim in neutropenia, sponsored by BIOCAD. Started Sep 2013; status: completed.
02
Drugs
empegfilgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT02104830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02104830.